BUY Cipla Ltd. — Vaishali Parekh, Prabhudas Lilladher
byVaishali Parekh, Prabhudas LilladherHorizon: 1–3 months1 Jun 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Cipla shares gain after it inks cancer treatment drug licensing deal with Sino Biopharma arm
NewsCnbc-Tv18·1 Sept · today
Cipla licenses experimental HER2 cancer drug for India, South Africa and five other markets
NewsCnbc-Tv18·31 Aug · today
Cipla Ltd has signed an exclusive licensing agreement with SBP Group for Rolditamig Deuderuxtecan (TQB2102), a potential best-in-class HER2 bispecific ADC.
BSE · Company Update·31 Aug · today
8 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·31 Aug · yesterday
2 other SEBI-registered advisors have active short-term BUY calls on this stock
Advisor consensus · same horizon·7 Jul · 2mo ago
US FDA classifies Cipla subsidiary’s New York facility inspection as ‘Voluntary Action Indicated’
NewsCnbc-Tv18·29 Aug · 3d ago
Cipla Pharma License Cancellation: FDA Withdraws Order After HC Raps It For Going "Overboard"
NewsNdtv-Profit·29 Aug · 3d ago
Cipla shares slip after USFDA observations; Citi says no earnings impact, target at ₹1,700
NewsCnbc-Tv18·26 Aug · 6d ago
Nifty, Sensex open lower; TCS, Eternal gain, Cipla, Maruti slip
NewsHbl·25 Aug · 1w ago
Nifty, Sensex open lower on Iran sanctions, tech selloff; TCS, Eternal gain while Cipla, Maruti slip
NewsHbl·25 Aug · 1w ago
Cipla Pharma license cancellation: FDA withdraws order after Bombay HC raps it for going 'overboard'
NewsCnbc-Tv18·29 Aug · 2d ago
FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads
NewsNdtv-Profit·28 Aug · 3d ago
Cipla gets seven USFDA observations for Pithampur plant after follow-up inspection
NewsCnbc-Tv18·25 Aug · 6d ago
3 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·24 Jul · 1mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.